hrp0082p2-d2-463 | Growth (1) | ESPE2014

Recombinant Human GH Effects on Growth and Clinical Status in Cystic Fibrosis

Ghergherehchi Robabeh , Rafeey Mandana , Habibzadeh Afshin , Zamani Masoud , Ansarin Khalil , Shabestari Mahnaz Sadeghi

Background: Growth retardation is a common finding in cystic fibrosis (CF) patients. Recombinant human GH (rhGH) has shown promising results in improving weight, height and clinical status of CF patients.Objective and hypotheses: In this study we aim to evaluate efficacy of rhGH on growth and clinical status in CF patients.Method: In this prospective clinical trial we recruited 34 CF patients (58.8% male with mean age of 62.05&#177...

hrp0084p2-344 | Fat | ESPE2015

Configuring a Better Estimation of Obese Children’s Kidney Size

Soheilipour Fahimeh , Rahimzade Nahid , Jesmi Fatemeh , Pishgahroudsari Mohadeseh , Kaviani Sarah , Sadeghian Mahnaz , Almassinokiani Fariba

Background: Obesity ignites numerous health and psychosocial problems and is associated with various comorbidities. BMI is also independently associated with improved risk for numerous kidney disorders. As renal length is considered a vital parameter in the clinical assessment of renal patients, normal renal length has to be defined in accordance to BMI. The aim of this study is to define normal kidney length in obese children, comparing ultrasound measurements of the kidney l...